Novartis focuses its business on three leading divisions with strong innovation power and global scale: pharmaceuticals, eye care and generics. These three leading divisions are supported by our research organization, the Novartis Institutes for BioMedical Research (NIBR), and a centralized services group, Novartis Business Services, to facilitate collaboration across our divisions, and drive efficiency and productivity gains.
We aim to develop innovative products in growing areas of healthcare. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.
Our Novartis Pharmaceuticals Corporation Innovative Medicines Executive Committee (IMEC) consist of respected industry leaders and visionaries who share a common passion for innovation and excellence in execution.